Anifrolumab (Saphnelo) March 6, 2024

March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024.

The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is posted.

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Nuvaxovid in Canada: How to Access the COVID-19 Vaccine

Read

Oral Ulcers and Lupus: More Than a Mouth Sore | Lupus Canada

Read

Lupus and Heart Health: Understanding Cardiovascular Risk in SLE

Read